Macquarie Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.06M | Buy |
|
|||||
|
2025
Q2 | $782K | Hold |
|
|||||
|
2025
Q1 | $717K | Sell |
|
|||||
|
2024
Q4 | $1.1M | Buy |
|
|||||
|
2024
Q3 | $823K | Buy |
|
|||||
|
2024
Q2 | $704K | Sell |
|
|||||
|
2024
Q1 | $622K | Buy |
|
|||||
|
2023
Q4 | $357K | Buy |
|
|||||
|
2023
Q3 | $340K | Sell |
|
|||||
|
2023
Q2 | $286K | Sell |
|
|||||
|
2023
Q1 | $382K | Hold |
|
|||||
|
2022
Q4 | $393K | Buy |
|
|||||
|
2022
Q3 | $296K | Sell |
|
|||||
|
2022
Q2 | $278K | Sell |
|
|||||
|
2022
Q1 | $424 | Hold |
|
|||||
|
2021
Q4 | $361K | Sell |
|
|||||
|
2021
Q3 | $982K | Buy |
|
|||||
|
2021
Q2 | $910K | Sell |
|
|||||
|
2021
Q1 | $1.24M | Hold |
|
|||||
|
2020
Q4 | $1.04M | Sell |
|
|||||
|
2020
Q3 | $5.49M | Buy |
|
|||||
|
2020
Q2 | $6.9M | Sell |
|
|||||
|
2020
Q1 | $18.2M | Hold |
|
|||||
|
2019
Q4 | $19.8M | Buy |
|
|||||
|
2019
Q3 | $13.8M | Hold |
|
|||||
|
2019
Q2 | $18.5M | Buy |
|
|||||
|
2019
Q1 | $23.2M | Buy |
|
|||||
|
2018
Q4 | $485K | Sell |
|
|||||
|
2018
Q3 | $693K | Sell |
|
|||||
|
2018
Q2 | $3.28M | Sell |
|
|||||
|
2018
Q1 | $2.7M | Sell |
|
|||||
|
2017
Q4 | $3.67M | Sell |
|
|||||
|
2017
Q3 | $77.6M | Buy |
|
|||||
|
2017
Q2 | $32.5M | Buy |
|
|||||
|
2017
Q1 | $30M | Buy |
|
|||||
|
2016
Q4 | $33.3M | Buy |
|
|||||
|
2016
Q3 | $41M | Sell |
|
|||||
|
2016
Q2 | $98.5M | Buy |
|
|||||
|
2016
Q1 | $68.1M | Sell |
|
|||||
|
2015
Q4 | $132M | Sell |
|
|||||
|
2015
Q3 | $197M | Sell |
|
|||||
|
2015
Q2 | $281M | Sell |
|
|||||
|
2015
Q1 | $343M | Sell |
|
|||||
|
2014
Q4 | $428M | Sell |
|
|||||
|
2014
Q3 | $442M | Buy |
|
|||||
|
2014
Q2 | $427M | Sell |
|
|||||
|
2014
Q1 | $463M | Sell |
|
|||||
|
2013
Q4 | $411M | Buy |
|
|||||
|
2013
Q3 | $345M | Buy |
|
|||||
|
2013
Q2 | $301M | Buy |
|